Immature T cell lymphomas represent a sig nificant portion of human lymphoid malig nancies (Ferrando and Look, 2000; Armstrong and Look, 2005) . Approximately 50% of these tumors harbor recurrent chromosomal translo cations (Aifantis et al., 2008) , which likely arise through errors in the repair of DNA double strand breaks (DSBs). In this context, normal mouse and human thymocyte differentiation requires V(D)J recombination, a process that in volves the introduction of DSBs at T cell recep tor (Tcr) loci by the recombinationactivating gene (RAG) 1 and 2 endonuclease (Bassing et al., 2002) . If such programmed Tcr DSBs are repaired incorrectly, they can generate chro mosomal translocations that involve Tcr loci. In fact, 70% of recurrent translocations in human T cell acute lymphoblastic leukemias (TALL) involve TCR loci (Aifantis et al., 2008) . Fur thermore, RAGinitiated DSBs in and around T cell oncogene loci may also contribute to clonal translocations in T cell lymphoma (Aifantis et al., 2008) . In addition, developing T cells are also subject to general DSBs that occur during S phase in association with periods of rapid cel lular division. These DSBs apparently can occur in numerous chromosomal locations, and po tentially participate in Tcr locusrelated translo cations (Bassing et al., 2003) .
characterized by immunodeficiency, genomic instability, and lymphoid malignancies (Lavin, 2008) . Most T cell malig nancies in AT patients are TALLs, which have not been well characterized cytogenetically. However, older AT pa tients who harbor clonal expansions of peripheral T cells with inv(14)(q11;q32), t(14;14)(q11;32.1), or rarely, t(X;14)(q28;q11) translocations, sometimes develop T cell prolymphocytic leukemia (TPLL; Pekarsky et al., 2001 ). The inv(14)(q11;q32), t(14;14)(q11;32.1), or t(X;14)(q28;q11) translocations appear to involve TCRA/D at 14q11 in hu mans and the T cell leukemia/lymphoma 1 (TCL1) (14q32.1) and MTCP1 (Xq28) oncogene loci, respectively (Russo et al., 1989; Fig. S1 ). ATMdeficient mice recapitulate aspects of human AT (Barlow et al., 1996; Elson et al., 1996; Xu et al., 1996; Herzog et al., 1998; Borghesani et al., 2000) . In this regard, ATMdeficient mice have impaired thymocyte development with reduced CD3 expression on DP thymo cytes and decreased SP thymocyte numbers (Borghesani et al., 2000; Huang et al., 2007) , which is consistent with defective Tcra V(D)J recombination. Moreover, ATMdeficient mice succumb to DP thymic lymphomas with RAGdependent translocations, which often join the Tcra/d on chromosome 14 to the telomeric end of chromosome 12, where mouse Tcl1 is located. Thus, it has been speculated that the inv(14) or t(14;14) in human TPLL and the t(12;14) in mouse ATMdeficient thymic lymphoma both may activate TCL1 or another dominant oncogene in this chromosomal region (Liyanage et al., 2000; Callén et al., 2009; Fig. S1) .
We now characterize recurrent translocations in mouse ATMdeficient thymic lymphomas in depth and also test for roles of E in tumor development. Surprisingly, we find that the recurrent chromosome 14 translocations observed in ATM deficient thymic lymphomas are associated with V(D)J recom bination errors at Tcrd, as opposed to Tcra locus. In addition, we show that E is completely dispensable for the oncogenic processes leading to these tumors. Finally, we show that most of these tumors amplify a set of genes lying just upstream of the Tcra/d locus. Based on our findings, we propose a model for the generation of the recurrent genomic abnormalities in ATMdeficient thymic lymphomas (Fig. S1 ).
RESULTS

Recurrent amplification upstream of Tcra/d locus in ATM-deficient thymic lymphomas
We used comparative genomic hybridization (CGH) to assay for genomic alterations in DNAs prepared from 18 indepen dent thymic lymphomas that arose in mice homozygous for an ATMinactivating mutation that we have previously de scribed (Borghesani et al., 2000) . In addition to copy number losses associated with V(D)J recombination at Tcr, , /, or immunoglobulin heavy chain (Igh) loci, one of the most strik ing features of the CGH profiles of these tumors was the common amplification of chromosome 14 sequences. Notably, the telomeric end of the amplification region always began upstream of the Tcra J region segments, frequently within the Tcrd portion of the Tcra/d locus or, in a few cases, upstream (5) During T cell development in the thymus, TCR variable region gene exons are assembled by V(D)J recombination that is initiated by RAGgenerated DSBs between V, D, and J segments and their flanking recombination signal sequences (RSSs; Rooney et al., 2004a) . To complete V(D)J recombi nation, RAGinitiated coding sequence DSBs and RSS DSBs are joined to each other by the classical nonhomologous endjoining pathway (CNHEJ; Rooney et al., 2004a; Lieber, 2008) . The V(D)J recombination process is also influenced by general DSB response factors such as the ataxia telangiec tasia mutated (ATM) protein (Liyanage et al., 2000; Bredemeyer et al., 2006; Callén et al., 2007; Huang et al., 2007) . In humans and mice, the two distinct lineages of T lymphocytes are dis tinguished by the surface expression of either  or  TCRs (Bhandoola et al., 2007) . TCR, , and  variable region exons are assembled in CD4  /CD8  (doublenegative) thy mocytes (von Boehmer, 2004) . Productive VDJ and VJ rearrangements generate TCR  and  chains that form cell surface  TCR and prescribe  T cell expansion and development (Krangel et al., 1998) . Productive VDJ re arrangements generate TCR chains, which, in conjunction with Notch1 signaling, promote differentiation to the CD4 + / CD8 + (double positive; DP) stage, in which Tcra rearrange ments occur (Garbe and von Boehmer, 2007) . Productive VJ rearrangements generate TCR chains that associate with TCR and promote further differentiation to CD4 + or CD8 + singlepositive (SP) mature T cells.
In both humans and mice, the TCRA and TCRD genes are encoded within the same locus (TCRA/D; Krangel et al., 2004) . The mouse Tcra/d locus lies on chromosome 14, with the C exons, which lie at the 3 (telomeric) end of Tcra/d, being preceded upstream by 60 J segments (Krangel et al., 2004; Fig. S1 ). The C exons lie upstream of the J segments and are flanked downstream by the V5 segment and upstream by a V4 segment, two D segments, and two J segments. Most V and V segments lie upstream of V4 with V segments lying at the distal (5 or centromeric) end of the cluster, V/V segments in the center, and V segments at the downstream (telomeric) end (Krangel et al., 2004) . Because of the unique Tcra/d organization, joining of V and J segments deletes the Tcrd portion of the locus (including C), permanently committing to the TCR/ lineage. V to J rearrangement requires the Tcra enhancer (E) at the 3 end of Tcra/d locus (downstream of C) to promote V(D)J recombinational accessibility of J segments lying up to 100kb away (Sleckman et al., 1997) . E also activates TCR expression (Sleckman et al., 1997) . The human TCRA/D locus is similarly organized and lies on human chromosome 14 (Fig. S1 ).
DNA DSBs, including V(D)J recombination DSBs, activate the ATM kinase, which then phosphorylates sub strates involved in DNA repair and cell cycle control (Kastan et al., 2001) . Although not required for V(D)J recombination, ATM helps promote normal DSB repair during this process (Bredemeyer et al., 2006; Callén et al., 2007; Huang et al., 2007) . Human ATM mutations cause AT, which is of the Tcra/d locus. In all cases, the amplification region we observed extended well beyond the centromeric end of the Tcra/d locus ( Fig. 1 B and Fig. S2 ). We observed amplifica tion of this general region in all 18 Atm / thymic lympho mas analyzed; albeit to differing extents of amplification and with amplicons in given tumors that ranged from 500 kb to >20 megabases (Mb; Fig. 1 B) . The amplified sequences common to all tumors comprised an 500kb genomic re gion that lies 10 Mb centromeric to the most 5 V of the Tcra/d locus (Fig. 1 B) . We independently confirmed amplification of this region in multiple independent Atm / thymic lymphomas by performing Southern blotting analyses with probes derived from the commonly amplified 500kb region (Fig. 1, B and C) .
We found several other recurrent copy number changes, in addition to the recurrent amplifications, including hemi zygous deletion of the putative Bcl11b tumor suppressor gene (chromosome 12) in 21/23 cases ( Fig. 1 A and Fig. S3 , A-C), homozygous deletion of the Pten tumor suppressor gene (chromosome 19) in 6/18 cases ( Fig. 1 A and Fig. S1 C) , and amplification of Notch1 oncogene (chromosome 2) in 5/18 cases ( Fig. 1 A and Fig. S2 B) . The latter findings led us to sequence the coding exons of Notch1 in 46 independent Atm / thymic lymphomas, including 14 analyzed by CGH (including three Notch1amplified tumors). We found Notch1 mutations in 18/46 cases (39.1%; Fig. S3 D) . Of the 20 muta tions found (2 out of 18 cases had two independent muta tions), 15 were proline/glutamic acid/serine/threoninerich domain mutations (75%), and 5 were heterodimer domain mutations (25%; Fig. S3 D) . Notably, the three Notch1 amplified tumors sequenced (tumor 5534 [ Fig. S3 B] , 5696, and 6099) had no Notch1 mutations, suggesting that amplifi cation of Notch1 gene might act as an independent means of Notch1 activation in Atm / thymic lymphomas.
The most frequent translocation in mouse ATMdeficient thymic lymphomas is a t(12;14) (Liyanage et al., 2000) . To characterize potential relationships between the recurrent gene amplification on chromosome 14 and this recurrent translocation, we first used chromosome 12 and 14 paints to assay for chromosomal anomalies in metaphase spreads from individual Atm / thymic lymphomas. Of 10 tumors ana lyzed, 7 had a clonal t(12;14), with clonality defined as the translocation occurring in 50% or more of the metaphases analyzed ( Fig. 2 B, Fig. S4 B, and Table S1 ). Most meta phases also contained, in addition to the t(12;14), a chromo some 14 fragment, referred to as f(14), plus apparently normal chromosomes 14 and 12 ( Fig. 2 C, Fig. S2 , and Fig. S4 C) . To further characterize potential anomalies, we stripped the paints from these metaphases and assayed them via fluores cence in situ hybridization (FISH) with a probe derived from the 3 (telomeric) end of the Tcra/d locus (CRed; Liyanage et al., 2000) and a probe derived from the centromeric region of chromosome 14 (RP23_145L1; referred to as ch14cen Green; Fig. 2 C and Fig. S4 C) . The t(12;14) retained sequences hybridizing to the C probe in the vicinity of the junction, but lacked ch14cenhybridizing sequences (Fig. 2 C and About 10 µg of genomic DNA from kidney (K) and the corresponding tumors (T) was digested with EcoRI and probed with the probe described in B (Chr14 Amp) and with probes that recognize the Tcrd constant region (C) or the Tcra (C). The red arrows indicate tumor samples with significant amplification. The blue arrowheads indicate the retention of C in those tumors. The asterisks mark the two samples that show C deletion as predicted by CGH analysis (Fig. 3 B) . The loading control probe was derived from an intron of the Mdc1 gene (which lies on mouse chromosome 17). M, DNA Marker; C, control DNA from 129sv mouse strain; B6, control DNA from BL6 mouse strain. Fig. S4 C, second row, top), which is consistent with the t(12;14) resulting from fusion of the 3 region of the Tcra/d locus (including E) with chromosome 12. These analyses also revealed an apparently normal chromosome 14 that con tained both ch14cen and Chybridizing sequences and a portion of chromosome 14 that contained the ch14cen hybridizing sequences but lacked Chybridizing sequences (see following paragraph; Fig. 2 C and Fig. S4 C, second row, top). As would be expected, the normal chromosome 12 did not hybridize to either C or ch14cen probes ( Fig. 2 C and Fig. S4 C, second row, top). Finally, we stripped the slides and applied a probe from the center of the common amplification region (green; RP23_359O5, referred as Amp) and a C probe (red) . In all eight samples tested, the C probe did not hybridize to f(14), whereas the Amp probe gave an intense signal on the f(14), which is consistent with amplification of these sequences in that location; however, no Amp probe signal was detected on the t(12;14) ( Table S1 ; see following para graph). Together, these latter results are consistent with the f(14) being a partner in the t(12;14) translocation (Fig. S2 ).
To unequivocally determine whether Tcra/d locus breaks contribute to the t(12;14) translocation, we prepared another set of metaphase spreads from 7 tumors with t(12:14) translocations and hybridized them with chromosome 12 (green) and chromo some 14 (red) paints first, and then stripped them and hybridized with the C probe (red) as well as a 5Tcra/d probe (green; RP23_304L21 derived from 6 kb upstream of the most 5V). In all seven sets of tumor metaphases analyzed, 5Tcra/d hybrid izing sequences were absent from the t(12;14) ( Table S1 ). Moreover, while Chybridizing sequences were not observed on the 14(f) in any of the seven tumor samples, five of seven samples did contain 5Tcra/d hybridizing sequences on the 14(f) (Fig. 2 C, Fig. S4 C, middle, and Table S2 ). Together, these findings suggest the t(12;14) was generated from breaks within the Tcra/d locus that split the locus into the t(12;14) and the 14(f). Finally, to look for a potential reciprocal t(14;12) trans location and to test if the telomeric portion of chromosome 12 is lost during the t(12;14) translocation, we sequentially hybrid ized six independent sets of metaphases with chromosome 14 plus chromosome 12 paints, and then a FISH probe derived from sequences just 3 (centromeric) to the Igh locus (199; red), which lies near the telomeric end of chromosome 12. Although the normal chromosome 12 in the metaphases always had a clear signal for the 3 Igh 199 probe, this probe did not hybridize to the t(12;14) translocation, indicating that the chromosome 12 junctional region within the t(12;14) translocations in ATM deficient thymic lymphomas generally is located centromeric to the Igh locus ( Table S3 ).
ATM-deficient thymic lymphomas derive from cells that have not attempted Tcra rearrangement
Aberrant TCRA rearrangement has long been proposed as the cause for the recurrent chromosome 14 translocations in Fig. S4 , and a summary of all slides analyzed is shown in Table S2 . (D) Representative FISH analysis of using the Amp BAC (359O5 in green) and C BAC (in red) on metaphases from ATM-deficient thymic lymphomas. A white arrow indicates the amplified 359O5 signal and a yellow arrow indicates the isolated C. A pink arrow indicates the normal chromosome 14 containing both the Amp and C (without amplification) signals. Other representative analyses are shown in Fig. S4 , and a summary of all slides analyzed is shown in Table S3 . At least 10 (usually 20) independent metaphases were scored for each tumor shown in the representative examples shown in this figure. The figures show results that were found in least 50% (often >85%) of the metaphases scored from each slides.
but not Tcra rearrangement. To confirm the CGH result, we probed EcoRIdigested DNA from 11 representative Atm / thymic lymphomas and corresponding kidneys with a probe from the C region and found that 9 out of 11 tumors re tained C, which in comparison to the kidney DNA signal appeared to be present biallelically in most tumors (Fig. 1 C) . Notably, the Southern blot analysis also confirmed the ho mozygous deletion of C in the two cases predicted by CGH analysis (456 and 535; marked with an asterisk in Fig. 1 C and  Fig. 3 B) . As a control, all of the tumors analyzed (with the exception of tumor 277, in which the tumor DNA was sub stantially degraded) retained the C probe (Fig. 1 C) . Together, these results indicate that ATMdeficient thymic lymphomas often derive from immature T cells that have not yet attempted Tcra rearrangement.
Molecular characterization of t(12;14) translocations in ATM-deficient thymic lymphomas
We used the high density CGH profile to analyze the chro mosome 12 status in 18 ATMdeficient thymic lymphomas. Consistent with loss of the 3Igh locus probe (199) from the t(12;14), as determined by FISH ( Fig. 2 C and Fig. S4 C, bottom), and the absence of t(14;12) reciprocal transloca tions, the CGH analyses revealed that 14 of the 18 analyzed tumors had hemizygous deletions of the telomeric portion of chromosome 12 ( Fig. 1 A and Fig. S3 , A-C) with the deletions ranging from 5-30 Mb (Fig. 4 A) . Copy number losses in highdensity CGH analyses allowed us to roughly estimate the region of chromosome 12 containing the t(12;14) trans location junction in 23 Atm / thymic lymphomas (includ ing 5 Atm / tumors from mice that also lacked E, referred to as E / ; see last section of Results). We found that t(12;14) translocation junctions in individual tumors were widely spread over an 28 Mb region of the telomeric portion of chromosome 12 (Fig. 4 A) , regardless of E status (Fig. 4 A; filled triangles denote Atm / tumors and open triangles de note E / Atm / tumors).
The TCL1 oncogene, which is involved in some translo cations with the TCRA/D locus in T cell lymphomas from human AT patients, maps to mouse chromosome 12. Our CGH data indicate that many of the translocations (14 of 23) we have characterized in mouse Atm / lymphomas involve chromosome 12 regions centromeric to Tcl1 and, thus, would delete the Tcl1 gene from the chromosome 12 involved in t(12;14) translocation, as previously found in analyses of a more limited set of tumors (Fig. 4 A; Liyanage et al., 2000) . In this context, we verified that the t(12;14) translocations in four of six analyzed Atm / thymic lymphomas lacked TCL1 (Fig. S4 A) . Likewise, arraybased expression analysis of these six ATMdeficient thymic lymphomas indicated that Tcl1 expression is not significantly different among lymphomas and normal thymocytes and similar in all lymphomas, whether or not Tcl1 was retained on the t(12;14) (Fig. S5 B) . This is in contrast with the overexpression of TCL1 described in human patients with t(14;14) or inv (14) translocations (Chun et al., 2002) . We also found that Bcl11b, which in some ATMdeficient thymic lymphomas (Callén et al., 2007; Huang et al., 2007; Liyanage et al., 2000) . As most develop ing T lymphocytes in mice that rearrange the Tcra locus do so on both alleles and delete the Tcrd locus (Krangel et al., 2004) , the hypothesis that recurrent chromosome 14 translocations in Atm / thymic lymphomas involve aberrant Tcra locus re arrangements would imply that these tumors should fre quently show biallelic deletions of, at least, a portion of J and complete deletion of the C region. To test this, we ana lyzed highdensity CGH data in and around the vicinity of Tcra/d locus and found that 16 out of 18 ATMdeficient thymic lymphomas, in fact, retained the C region (Fig. 3, A and B) , suggesting that the Atm / thymic lymphomas derived from immature thymocytes that have not yet attempted Tcra re arrangement. Homozygous deletion of a particular genomic region is defined by an LN2 (CGH signal tumor/control kid ney) lower than 1.6 (Fig. 3 A) . By this criterion, 16 out of the 18 Atm / thymic lymphomas have homozygous deletions between the V4 and D2 segments, but not in other regions in the Tcra/d locus (Fig. 3, A and B) , again suggestive of Tcrd Fig. 1 C) .
sequences situated just centromeric of the chromosome 12 deletion in particular tumors and the other came from the D/J area on chromosome 14. By this approach, we were able to isolate and sequence putative PCR translocation junc tion products from two tumors (8102 and 8174; Fig. 4 B) . In both cases, the chromosome 14 side of the junction was adja cent to a canonical RSS sequence within the Tcrd locus and, in one case, the junction included a potential P element (Fig. 4 B ; P element in green and underlined), strongly indicat ing that these translocations derived from DSBs generated during V(D)J recombination. However, the two putative chromo some 12 breakpoints, which were 10 Mb apart, were rather unremarkable. There was no evidence of a cryptic RSS in this region. The next known coding transcripts on chromosome 12 (predicted by mouse genome version mm8) are 30 kb (8174) and 752 kb (8102) away from the breakpoints.
The Tcra/d and Igh Loci often lie in close proximity in thymocytes ATM is required for normal endjoining during V(D)J re combination at both the Igh locus in developing B cells and the Tcra/d locus in developing T cells, and ATM is also re quired to mediate checkpoints that eliminate developing ATMdeficient B and T cells with breaks at their antigen re ceptor loci (Liyanage et al., 2000; Callén et al., 2007; Huang et al., 2007) . Correspondingly, developing B and T cells sometimes suffer unrepaired V(D)J recombination associated DSBs at their Igh or Tcra/d loci, respectively, that persist and can be substrates for translocations (Callén et al., 2009) . In this regard, developing T lymphocytes frequently undergo D to J rearrangements at their Igh loci (Züñiga et al., 1982) . Thus, the frequent occurrence of unrepaired V(D)J recombinationassociated DSBs at the Igh and Tcra/d loci in the progenitors of ATMdeficient thymic lymphomas may be a major con tributor to the frequent occurrence t(12;14) translocations in ATMdeficient thymic lymphomas. Indeed, t(12;14) transloca tions have been observed in nonmalignant ATMdeficient peripheral T cells (Liyanage et al., 2000; Callén et al., 2007 Callén et al., , 2009 . Loci that are frequently broken in normal cells have, in some cases, been found to translocate at very high fre quency (Wang et al., 2009 ); and such high frequency translo cations have been found to also correlate with close proximity of the loci in the interphase nucleus (Wang et al., 2009) . To further explore the latter possibility, we used interphase 3D FISH to assay the proximity of the Tcra/d and Igh loci in the interphase nucleus of thymocytes. Although we found only 1% of Tcra/d and Igh loci colocalized at a resolution of 0.5 µm (Fig. S7, A-E) , we found that Tcra/d colocalized with Igh in 12-19% of thymocytes (Fig. S7, A-E ) when measured at a resolution of 1 µm, which appeared significant as only 4-5% of thymocytes showed colocalization of their two Tcra/d loci and <1% of thymocytes showed colocalization of their two Igh loci at the 1µm level of resolution (Fig. S7,  A-E) . Thus, the frequent proximity of the Igh and Tcra/d loci in total thymocytes is consistent with proximity also playing a role in promoting recurrent t(12;14) translocations. experimental backgrounds has been implicated as a haplo insufficient tumor suppressor in mice (Kamimura et al., 2007) and which has been found to be involved in translocations in human TALL (MacLeod et al., 2004; Przybylski et al., 2005; Su et al., 2006) , is deleted from the chromosome 12 involved in the t(12;14) translocations in 21 of 23 ATMdeficient thy mic lymphomas we characterized (Fig. 4 A) . In this context, arraybased expression analyses of three ATMdeficient thy mic lymphomas showed apparently reduced Bcl11b expres sion levels (15-30% of WT thymocyte levels; Fig. S6 C) To gain further insight into molecular mechanisms that lead to the recurrent t(12;14) translocations in Atm / thymic lymphomas, we further analyzed the CGH data and designed sets of PCR primers that might amplify transloca tion junctions. One primer in a given set derived from . Both junctions were independently PCR amplified, cloned (in duplicate), and sequenced from both ends. The arrows on the diagram and arrowheads on the sequences indicate the position of the breakpoints in chromosomes 14 and 12. In the sequence diagrams, sequences corresponding to germ line chromosome 12 sequences are presented in blue and those corresponding to germ line Tcrd sequences (chromosome 14) are shown in red. The black letters in junction 8174 indicate nucleotides that could not be unequivocally matched to either side of the junction (e.g., potential insertions). The underlined, green letters in junction 8102 (GAT and A) are potential palindromic (P) elements. The canonical RSS sequences for the involved J and D segments are underlined. and amplifications of the common amplification region upstream of Tcra/d locus.
Together, our findings suggest that aberrant resolution of DSBs generated during Tcrd V(D)J recombination in ATM deficient doublenegative thymocytes leads to chromosome However, we also must note that it is not yet clear if Igh breaks are indeed intermediates in most t(12;14) transloca tions in ATMdeficient thymic lymphomas or what the rela tive proximity of these two loci is in the actual thymocyte progenitors of these tumors.
Atm / E / mice developed thymic lymphomas with clonal translocations involving the Tcrd locus To test putative roles of E in thymic lymphomagenesis in the ATMdeficient background, we generated Atm / E -/ mice by crossbreeding mice harboring these mutations. SP  T cells are basically absent in Atm / E / mice (Fig. 5 A) , which is consistent with the requirement for E for the vast majority of V to J rearrangements (Krangel et al., 2004 ). Yet, total thymocyte numbers are increased in Atm / E / mice in comparison to Atm / mice, potentially suggesting aberrant Tcra rearrangement in the absence of ATM might contribute to reduced total thymic cellularity in Atm / mice (Fig. 5 A) . Notably, Atm / E / mice still succumbed to DP thymic lymphomas with average survival of 103 ± 28 d, which is not significantly different from that observed in their Atm / counterpart (119 ± 30 d, P value = 0.65; Fig. 5 BA) . Cytogenetic analysis of five Atm / E / thymic lympho mas revealed clonal chromosome 14 translocations in all cases analyzed (Fig. 5 C) , and CGH analyses revealed characteristic amplifications and t(12;14) translocations that are indistin guishable from those of their Atm / counterparts (Fig. 5 D) , indicating that neither E driven Tcra V(D)J recombination nor E driven oncogene expression are essential for the gen eration of ATMdeficient thymic lymphomas with chromo some 14 translocations/amplifications.
DISCUSSION
Most immature T cell lymphomas from ATMdeficient mice have a CD4 + CD8 + DP phenotype (Barlow et al., 1996; Borghesani et al., 2000) . Thus, these tumors have generally been thought to derive from developing thymo cytes that attempted and failed to undergo normal Tcra gene rearrangement (Liyanage et al., 2000; Callén et al., 2009) . Correspondingly, recurrent chromosome 14-related translocations in ATMdeficient mouse thymic lympho mas have often been attributed to aberrant Tcra rearrange ments and cellular selection for Emediated oncogene overexpression (Liyanage et al., 2000; Callén et al., 2009) . In contrast to these expectations, we find that the recur rent t(12;14) translocations in ATMdeficient thymic lym phomas derive from misrepair of DSBs generated during V(D)J recombination at the Tcrd locus. This conclusion is indicated by our finding of an intact C region in most ATMdeficient thymic lymphomas ( Fig. 1 C and Fig. 3 ) and also by our finding of t(12;14) translocations that have breakpoints within the Tcrd locus (Fig. 4 B) . In this con text, although E is required for normal Tcra rearrange ment (Sleckman et al., 1997) , our findings clearly demonstrate that E is not required for development of ATMdeficient thymic lymphomas harboring clonal t(12;14) translocations respectively. The fact that the vast majority of the genomic sequence of human chromosome 14 maps either to mouse chromosomes 12 or 14 (Fig. S1) suggests that there may po tentially be selection of a common target with respect to the human inv(14) or t(14;14) and mouse t(12;14) translocations (Liyanage et al., 2000; Callén et al., 2009;  Fig. 2, Fig. S1 , Fig. S4 , and Table S1 ). One obvious candidate was TCL1, the proposed oncogenic target of the common inv(14)(q11;q32) or t(14;14)(q11;32.1) (Fig. S1) in TPLL from AT patients (Russo et al., 1989) . TCL1 maps to human chromosome 14q32 and to a position 105 Mb telomeric to the centromere of mouse chromosome 12 (Fig. 4 A and Fig. S1 ). The simple hypothesis would be that the recurrent t(12;14) translocations in mice might activate Tcl1 on chromosome 12 and be positively selected for transformation (Pekarsky et al., 2001) . However, Tcl1 is often deleted in the t(12;14) translocations (Fig. 4 A; Liyanage et al., 2000) , and we do not find TCL1 overexpression in ATMdeficient thymic lymphomas (Fig. S5 B) . Although there may be other chromosome 12 oncogenes activated via the recurrent t(12;14) translocations, this possibility seems unlikely given that the chromosome 12 junctional region of the t(12;14) translocations occur at various positions within a 28Mb region, regardless of whether the tumors are from cells in which E was present or absent (Fig. 4 A) . An alternative possibility is that the t(12;14) trans locations might result in hemizygous loss of a putative tumor suppressor gene that lies somewhere near the telomeric end of chromosome 12. In this regard, it is notable that one copy of Bcl11b, a putative haploinsufficient tumor suppressor in p53 +/ mouse thymic lymphomas (Kamimura et al., 2007) and potentially also in human TALLs (MacLeod et al., 2004 (MacLeod et al., , 2008 Przybylski et al., 2005; Su et al., 2006) is deleted in the context of the t(12;14) translocations in the vast majority (21 of 23) of the mouse Atm / thymic lymphomas. As might be expected, we observed reduced expression of Bcl11b and several other genes in the deleted region in a subset of tumors analyzed (Fig. S6 C) .
Another possibility is that t(12:14) translocation in mouse ATMdeficient thymic lymphomas might not directly con tribute to oncogenic transformation but, instead, may reflect a high frequency of the corresponding translocation in tumor progenitor cells caused by mechanistic factors. Such mecha nistic factors could include the occurrence of frequent unre paired RAGinitiated breaks in the Tcra/d and Igh loci in developing thymocytes (Callén et al., 2007 (Callén et al., , 2009 Huang et al., 2007) and, potentially, the relative proximity of these two loci in total thymocytes (Fig. S7) . In this regard, the ATMdeficient background would also promote persistence and frequent translocation of such DSBs (Callén et al., 2007) . Although the t(12;14) junctions are spread over a large (28 Mb) area downstream of Igh (Fig. 4 A) , it is still conceivable that some or all of them were initiated by RAG J H region DSBs, given findings that persistence of such Igh DSBs in developing ATMdeficient developing B cells persist often leads to substantial levels of downstream chromosomal se quence loss before they enter into translocations in mature 14 breaks that are aberrantly repaired in the absence of ATM, thereby leading both to recurrent gene amplifications on chromosome 14 and translocations involving chromosome 14 and 12. We note that mechanisms we describe for generating these recurrent forms of genomic instability in ATMdeficient mouse thymic lymphomas, to date, appear uniquely associated with ATM deficiency. Thus, a series of previously characterized thymic lymphomas that arise in other mutant backgrounds (e.g., NotchICN overexpression, p53 deficiency, H2AX/p53 deficiency, etc.) lack recurrent amplifications of chromosome 14 sequence and recurrent chromosome 14 or 12 translocations (Bassing et al., 2003 (Bassing et al., , 2008 Li et al., 2008; Giblin et al., 2009 ). Conceivably, the recurrent translocations found in ATM deficient thymocytes are associated with the unique combina tion of checkpoint and V(D)J recombination defects associated with ATM deficiency (Callén et al., 2007) .
We find that nearly all ATMdeficient thymic lympho mas harbor amplifications of a common 500kb region that lies 10 Mb upstream of the Tcra/d locus ( Fig. 1 and Fig. S2 ). We further show that this amplification occurs on a residual centromeric fragment of chromosome 14 and not on the recurrent t(12;14) ( Fig. 2 and Fig. S4 ). The fact that this amplification occurs in all 23 tested ATMdeficient thymic lymphomas strongly suggests that it may be linked to some stage of the oncogenic process that leads to the fullblown ATMdeficient thymic lymphomas. The commonly ampli fied region is relatively compact and appears to hold 16 genes (including 10 potential mRNA transcripts, 1 microRNA, and several noncoding transcripts according to University of California at Santa Cruz genome browser mouse gene annotation_2006 Feb version; Fig. S5 A) , none of which are known oncogenes. At this time, the precise contribution of this amplified region (and the amplified sequences that are contained within it) to the oncogenic process that generates ATMdeficient thymic lymphomas is unknown; although in many human tumors, gene amplification is associated with tumor progression as opposed to tumor initiation. Indeed, other genetic alterations that we describe in ATMdeficient thymic lymphoma (e.g., Notch1 mutation, Pten deletion, and chromosome 12 deletions) or, potentially, still unknown genetic alterations also likely contribute to the generation of these tumors. Expression array analyses indicated that 3 of 8 tested genes within the common amplification unit were overex pressed by 3-10fold ( Fig. S6 B) ; however, because passenger genes within amplicons are also often highly overexpressed (Kohl et al., 1983) , overexpression does not allow us to pin point a potential oncogene within the amplicon. In any case, the genes within the amplified region are candidates to test for genetic activities that can contribute to thymocyte tumor development in mice and, potentially, in humans (see last paragrpah of Discussion).
Why is chromosome 12 a frequent partner for chromosome 14 translocations?
The most common translocations in murine and human ATMdeficient thymic lymphomas, are t(12;14) and t(14;14), large chromosome 12 telomeric deletions, which might contribute to tumorigenesis, for example, by deletion of a tumor suppressor.
Implications for T cell lymphoma in AT patients
Although the mature T cell lymphomas from older AT patients contain characteristic translocations between the TCRA/D locus and a TCL1 family member (Russo et al., 1989) , the nature of the potential oncogenic events that contribute to the common immature T cell leukemia (TALL) in AT pa tients is still largely unknown. Developmentally, ATMdeficient murine thymic lymphomas resemble the developmental stage of human TALL. Our current finding of recurrent gene amplifications in ATMdeficient mouse thymic lymphomas suggests a previously unconsidered potential oncogenic mechanism (e.g., gene amplification) that may contribute to the generation of TALLs in human AT patients. In prelimi nary studies aimed at further elucidating this possibility, we performed CGH array analyses on a TALL sample from an AT patient, which showed an amplification of sequences lying at human chromosome 14q22 (Fig. S3 E) , which is the region of this human chromosome that corresponds to the amplified region we identified in mouse ATMdeficient thymic lymphomas. However, because of the unavailability of ap propriate materials, we were not able perform a more detailed characterization of these human TALL samples. Finally, our CGH analyses of ATMdeficient mouse T cell lymphomas revealed frequent activation of Notch1 (via mutation or am plification) and deletion of Pten ( Fig. 1 and Fig. S3 ). Both of these events are common in human TALL (Weng et al., 2004) . Therefore, further characterization of the oncogenic events leading to ATMdeficient thymic lymphomas, including defini tion of the target of the common gene amplification, may provide further insights into the etiology of human TALLs.
MATERIALS AND METHODS
Mice. We have previously described the ATMdeficient mice used in this study (Borghesani et al., 2000) . To generate the Atm / E / cohort, E / mice, which we also described previously (Sleckman et al., 1997) , were bred with Atm +/ mice to generate mice homozygous for both muta tions. Animal protocols were approved by the Institutional Animal Care and Use Committee of Children's Hospital Boston.
Southern blotting. Genomic DNA was isolated from tumors or normal tissues from control mice, and Southern blotting was performed with 10 µg of EcoRIdigested genomic DNA. The C probe was a 438bp fragment derived from intron1 of C, which was prepared via PCR amplification from genomic DNA using 5GAAGTGGCAGAGCATCTCGGTC3 and 5GTGGCATCACAGGGAACGTCTAAA3 primers. The C probe was a 508bp fragment derived from intron1exon3 and PCR amplified with 5CCTCTTGCCCTCAGCTTACC3 and 5CTTGGCAAA CAGCAGTCGTAG3 primers. The Amp probe is a 916bp PCR frag ment (described in more detail in the Results section) that was generated with 5AAGTGGCCGTGGATACTGA3 and 5GTATACAGGTG CAGCCGTTAAA3 primers.
Thymocyte development. Thymocyte populations were analyzed by flow cytometry, as previously described (Sleckman et al., 1997; Borghesani B cells (Callén et al., 2007 (Callén et al., , 2009 ). Finally, we note that there is a potential precedent for "mechanistically promoted" re current translocations; thus, the translocation of activation induced deaminase (AID)-dependent Igh DSBs to RAG dependent Ig DSBs in NHEJdeficient peripheral B cells is apparently so frequent in tumor progenitors that it leads to these translocations recurrently appearing in peripheral B cell lymphomas that arise from NHEJdeficient plus p53deficient B cells (Wang et al., 2008 (Wang et al., , 2009 ).
Model for the mechanism of recurrent translocations and amplifications in ATM-deficient thymic lymphomas Based our current findings and the considerations outlined above, we propose a working model to explain the transloca tions/amplifications found in ATMdeficient thymocytes (Fig. S2) . This model is based, in part from the model that we proposed to explain the recurrent appearance of complex translocations and amplifications, or "complicons," involving the Igh and c-myc loci in NHEJ/p53deficient pro-B cell lymphomas (Zhu et al., 2002) . This model proposes that Igh/c-myc complicons found in NHEJ/p53 deficient pro-B lymphomas arise by a mechanism in which RAGgenerated Igh breaks on chromosome 12 in NHEJ/p53deficient mouse pro-B cells are fused to chromosome 15 downstream of c-myc leading to dicentric chromosomes that promote c-myc ampli fication via a breakagefusionbridge (BFB) mechanism (Zhu et al., 2002) . By analogy, in ATMdeficient developing thy mocytes, unrepaired Tcrd locus breaks may lead to the gener ation of dicentric chromosomes that then go through a BFB cycle, facilitated by the checkpoint deficiency associated with ATM deficiency to allow amplification of the region up stream of Tcra/d (Fig. S2) . The fact that most amplicons begin within or upstream of Tcrd is consistent with this possibility, as sequences proximal to initiating DSBs are sometimes deleted during the translocation/amplification process (Zhu et al., 2002) . Dicentrics could be chromosome 14 fusions (after replication through Tcrd DSBs facilitated by the G1 check point deficiency in ATMdeficient cells [ Fig. S2] ) or fusions to DSBs on other chromosomes (Zhu et al., 2002; Rooney et al., 2004b) . In this regard, in preliminary studies we indeed observed an increased frequency of chromosome 14 dicen trics in IL7-stimulated thymocytes from ATMdeficient mice (freq = 0.95 ± 0.24%) versus WT mice (freq = 0 ± 0%; P value = 0.017 by Student's t test, between WT and Atm / mice; Fig. S7 F) . Involved chromosomal breaks outside of Tcrd might also be RAGinitiated or they may be generated by other factors (Fig. S2 ). In this model, chromosome 12, because of frequent and persistent unrepaired RAGinitiated breaks in the ATMdeficient background, might serve either as a partner to generate a dicentric or, because of frequent breaks and relative proximity, simply as a frequent recipient for persistent chromosome 14 breaks generating t(12;14) as a mechanistic "passenger" (Wang et al., 2009; Fig. S2) . Finally, this model would not rule out the possibility that frequent chromosome 14 to chromosome 12 translocations that oc curred in this context might be selected for those harboring (Jackson Immuno Research Laboratories) and were used at 1:200 dilution. Images of 50 serial optical sections spaced by 0.2 µm were captured with Marianas spinning disk confocal microscope (63×) with a chargecoupled device detector (Intelligent Imaging Innovations) and analyzed with Slide book software (Intelligent Imaging Innovations).
Array CGH analyses. For CGH, 5 µg of genomic DNA from ATM deficient mouse thymic lymphomas was profiled against 5 µg of matched normal kidney DNA from the same mouse. Genomic DNA processing, la beling and hybridization to 244k mouse Agilent CGH 60mer oligo arrays was performed at the Arthur and Rochelle Belfer Cancer Genomics Center at the DanaFarber Cancer Institute. Detailed features of the 244k mouse genome array can be found at http://www.agilent.com. Fluorescence ratios of scanned images were normalized and copy number profiles were gener ated by circular binary segmentation, which determines significance of change points in raw data through permutation (Olshen et al., 2004) . Thresholds for copy number alterations were set at log 2 = ±0.6 for trisomy or hemizygous deletion.
Online supplemental material. Fig. S1 diagrams the syntenic regions of human chromosome 14 and mouse chromosomes 12 and 14. Fig. S2 de scribes the prior and current models for potential mechanisms and roles of chromosome 12 and 14 translocations in ATMdeficient thymic lympho mas. Fig. S3 shows the CGH results and Notch1 mutation analyses of ATM deficient T cell malignancies. Fig. S4 shows additional examples of cytogenetic analyses of ATMdeficient thymic lymphomas. Cytogenetic analysis of chromosome 14 and the Tcra/d locus. To generate metaphases, freshly isolated ATMdeficient T cell lymphomas were made into singlecell suspensions and cultured in RPMI with 15% fetal bovine serum in the presence of 5 ng/ml recombinant mouse IL7 (R&D Systems) and 100 ng/ml colcemid (Invitrogen) for 6 h. Metaphases and twocolor FISH assays for Tcra/d locus breaks were performed essentially as previously described, with the indicated BAC probes . Chromosome paints were purchased from Applied Spectral Imaging. In brief, metaphases were first probed with fluorochromeconjugated paints to mouse chromosome 12 and 14, following the manufacturer's instructions. Metaphase images were captured using a Nikon Eclipse microscope equipped with a chargecoupled device camera (Applied Spectral Imaging) and a 63× objective lens. More than 10 (often 20) metaphases were analyzed for each independent sample. After image recording, selected slides were dehydrated through serial ethanol washes to strip the chromosome paints, and then re probed with fluorochromelabled BAC probes. To prepare the probes, BACs were labeled with either biotin (BiotinNick Translation Mix; Roche) or digoxigenin (DigNick Translation Mix; Roche), as per manufacturer in structions. 200 ng of BAC DNA was precipitated with mouse Cot1 DNA (Invitrogen; ratio of BAC DNA to Cot1 DNA, 1:20), resuspended in 15 µl of hybridization solution (50% formamide, 2X SSC, 10% dextran sulfate, and 0.15% SDS), and codenatured on slides for 5 min at 76°C. Slides were then incubated at 37°C for 16 h, washed twice in 50% formamide/2X SSC for 5 min at 45°C, washed twice in 2X SSC for 5 min at 45°C, and incu bated with avidinCy3 and anti-digoxigeninFITC (Roche; 1:250 dilution) in 2XSSC/0.05% Tween20 for 1 h at room temperature. After three washes in 2XSSC/0.05% Tween20, slides were mounted in Vectashield with DAPI (Vector Laboratories). Images were captured as outlined for chromo some paint.
Sequence of the coding exon of Notch 1 in ATM-deficient thymic lymphomas. Individual DNA samples (5 µg) from 50 different ATM deficient thymic lymphomas were subjected to exon sequencing as previ ously described (O'Neil et al., 2006) . Tumors had <10% contamination with normal cells as judged by Southern blotting with Tcrb locus probes (Khor and Sleckman, 2005) downstream of J1 and J2. We obtained clear se quence results from 46 out of 50 samples.
Cytogenetic analysis of chromosome 14 dicentric formation in developing thymocytes. To measure the chromosome 14 dicentric for mation, freshly isolated thymocytes were cultured in RPMI with 15% fetal bovine serum in the presence of 5 ng/ml recombinant mouse IL7 (R&D Systems) and 100 ng/ml colcemid (Invitrogen) for 6 h. Metaphase chromo some paints were performed as described previously .
Interphase FISH analyses of thymocytes from WT and ATM / mice. Threedimensional FISH was performed similarly to a previously de scribed procedure (Callén et al., 2007) . In brief, freshly isolated thymocytes were transferred to a glass slide coated with Cell Tak (BD), fixed for 10 min with 4% paraformaldehyde, permeabilized in 0.1% saponin/0.1% Triton X100 in PBS for 10 min, and immersed in liquid nitrogen for three freeze/thaw cycles. Slides were incubated in 0.1 M HCl, blocked with 3% BSA and 100 mg ml 1 RNase A, and repermeabilized in 0.5% saponin/0.1% Triton X100 in PBS. Genomic DNA was denatured at 73°C and hybridized with FISH probes labeled with either biotin or digoxin (Roche). Detecting antibodies were streptavidinAlexa Fluor 488 (Invitrogen) and mouse anti-Digcy3
